Insider Transactions in Q2 2022 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,211
+0.15%
|
$11,055
$5.0 P/Share
|
|
Jun 06
2022
|
Ran Nussbaum Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,030
+0.07%
|
$5,150
$5.0 P/Share
|
|
Apr 30
2022
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
254
-1.07%
|
$1,524
$6.62 P/Share
|
|
Apr 30
2022
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.06%
|
-
|